-
Mashup Score: 2Why not federalize Medicaid? - 4 year(s) ago
One way to end the debate fracturing Democrats and health care advocates
Source: gooznews.substack.comCategories: Latest Headlines, PayerTweet
-
Mashup Score: 1Non-profits to boost unproven Alzheimer's drug - 4 year(s) ago
Expect “patient assistance” foundations to jump into the Aduhelm fray
Source: gooznews.substack.comCategories: Hem/Oncs, Latest HeadlinesTweet-
US Non-profits to boost unproven @biogen Alzheimer's drug: Expect "patient assistance" foundations to jump into the Aduhelm fray https://t.co/dvKfwoxznH via @_GoozNews @MadhavThambiset @ProfRobHoward @barttels2 @gregggonsalves
-
-
Mashup Score: 3Non-profits to boost unproven Alzheimer's drug - 4 year(s) ago
Expect “patient assistance” foundations to jump into the Aduhelm fray
Source: gooznews.substack.comCategories: Latest Headlines, PayerTweet-
"Patient assistance scams are just one way pharmaceutical companies use kickbacks to increase sales of marginally useful or, in the case of Aduhelm, totally unproven drugs" @_GoozNews https://t.co/tbsXmJKU8M
-
-
Mashup Score: 0How does aducanumab compare? - 4 year(s) ago
Biogen’s new Alzheimer’s drug is an ideal candidate for comparative-effectiveness research.
Source: gooznews.substack.comCategories: Latest Headlines, PayerTweet-
Great suggestion by @_GoozNews for @PCORI to conduct a trial to compare aducanumab to home care coupled w/ physical & cognitive exercises. My guess: home care intervention would more effectively improve quality of life, cognitive status ... https://t.co/ZikvWSV7AH
-
-
Mashup Score: 7CMS should review the FDA’s Alzheimer drug decision - 4 year(s) ago
The Medicare Evidence Development & Coverage Advisory Committee should mandate outcomes data collection and analyze patient results.
Source: gooznews.substack.comCategories: Latest Headlines, PayerTweet-
Nice piece by @_GoozNews on next steps after FDA’s controversial Alzheimer's drug approval, esp given Biogen quintupled the expected price and listed at $56k: CMS needs to begin a National Coverage Determination process, requiring CED at the minimum https://t.co/CJe29hfgbO
-
-
Mashup Score: 0The vaccine IP sideshow - 4 year(s) ago
Big Pharma needs to transfer the technology so production can ramp up as quickly as possible. How is up to them.
Source: gooznews.substack.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
The vaccine IP sideshow, by @_GoozNews https://t.co/8MBSZALlMi @grumpeoldman @ramakumarr
-
-
Mashup Score: 1Medical device malpractice at CMS - 4 year(s) ago
Looming midnight rule could unleash a flood of untested products.
Source: gooznews.substack.comCategories: Latest Headlines, PayerTweet-
RT @_GoozNews: Medical device malpractice at CMS by @_GoozNews https://t.co/7iV9lrucSG @peterbachmd @tuftsCEVR @icer_review
-
RT @_GoozNews: Why not federalize Medicaid? by @_GoozNews https://t.co/wnRxv7nedj